Convergence Investment Partners, LLC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 137 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.

Quarter-by-quarter ownership
Convergence Investment Partners, LLC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q2 2018$1,169,000
-35.9%
74,357
-32.9%
0.16%
-31.5%
Q1 2018$1,824,000
+13.3%
110,861
+24.4%
0.24%
+10.2%
Q4 2017$1,610,000
-30.2%
89,121
-25.5%
0.22%
-33.9%
Q3 2017$2,308,000
+75.8%
119,602
+7.5%
0.33%
+70.3%
Q2 2017$1,313,000
-13.7%
111,231
-19.9%
0.19%
-10.3%
Q1 2017$1,521,000
+95.8%
138,800
+29.7%
0.21%
+100.0%
Q4 2016$777,000107,0400.11%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Consonance Capital Management LP 5,188,417$85,349,0007.80%
TANAKA CAPITAL MANAGEMENT INC 144,602$2,379,0005.69%
INGALLS & SNYDER LLC 6,817,540$112,149,0005.47%
NEXTHERA CAPITAL LP 1,045,196$17,193,0002.83%
Timpani Capital Management LLC 245,279$4,035,0001.41%
S&T BANK/PA 426,257$7,012,0001.25%
SHAKER INVESTMENTS LLC/OH 107,670$1,771,0001.10%
ESSEX INVESTMENT MANAGEMENT CO LLC 434,624$7,150,0000.94%
AMI ASSET MANAGEMENT CORP 709,300$11,668,0000.83%
Birchview Capital, LP 75,500$1,242,0000.82%
View complete list of CORCEPT THERAPEUTICS INC shareholders